Lumasiran sodium, an investigational RNA interference (RNAi) therapeutic agent, reduces hepatic oxalate production by targeting glycolate oxidase. Lumasiran sodium reduces urinary oxalate excretion, the cause of progressive kidney failure in primary hype
Molecular Weight:
17307.71
Purity:
95.37
CAS Number:
[1834612-06-4]
Formula:
C530H668F10N173Na44O320P43S6
Target:
Small Interfering RNA (siRNA)
Application Notes:
Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted